Literature DB >> 23324594

Neuronal Ca(2+) dyshomeostasis in Huntington disease.

Marta Giacomello1, Juan C Oliveros, Jose R Naranjo, Ernesto Carafoli.   

Abstract

The expansion of the N-terminal poly-glutamine tract of the huntingtin (Htt) protein is responsible for Huntington disease (HD). A large number of studies have explored the neuronal phenotype of HD, but the molecular aethiology of the disease is still very poorly understood. This has hampered the development of an appropriate therapeutical strategy to at least alleviate its symptoms. In this short review, we have focused our attention on the alteration of a specific cellular mechanism common to all HD models, either genetic or induced by treatment with 3-NPA, i.e. the cellular dyshomeostasis of Ca(2+). We have highlighted the direct and indirect (i.e. transcriptionally mediated) effects of mutated Htt on the maintenance of the intracellular Ca(2+) balance, the correct modulation of which is fundamental to cell survival and the disturbance of which plays a key role in the death of the cell.

Entities:  

Keywords:  Huntington; Huntington disease; calcium; mitochondria; transcription

Mesh:

Substances:

Year:  2013        PMID: 23324594      PMCID: PMC3609054          DOI: 10.4161/pri.23581

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  54 in total

1.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

Authors:  Fran Ledo; Leonor Kremer; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

3.  Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

Authors:  S J Tabrizi; J Workman; P E Hart; L Mangiarini; A Mahal; G Bates; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

4.  Ca2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2.

Authors:  Maulilio J Kipanyula; Laura Contreras; Enrico Zampese; Cristian Lazzari; Andrea K C Wong; Paola Pizzo; Cristina Fasolato; Tullio Pozzan
Journal:  Aging Cell       Date:  2012-08-07       Impact factor: 9.304

5.  Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Authors:  Caroline L Benn; Christian Landles; He Li; Andrew D Strand; Ben Woodman; Kirupa Sathasivam; Shi-Hua Li; Shabnam Ghazi-Noori; Emma Hockly; Syed M N N Faruque; Jang-Ho J Cha; Paul T Sharpe; James M Olson; Xiao-Jiang Li; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-09-23       Impact factor: 6.150

Review 6.  Ca2+-dependent transcriptional control of Ca2+ homeostasis.

Authors:  Jose R Naranjo; Britt Mellström
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

7.  Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity.

Authors:  Gaofeng Dong; Kylie Gross; Fangfang Qiao; Justine Ferguson; Eduardo A Callegari; Khosrow Rezvani; Dong Zhang; Christian J Gloeckner; Marius Ueffing; Hongmin Wang
Journal:  J Neurochem       Date:  2012-09-10       Impact factor: 5.372

8.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.

Authors:  Erica Rockabrand; Natalia Slepko; Antonello Pantalone; Vidya N Nukala; Aleksey Kazantsev; J Lawrence Marsh; Patrick G Sullivan; Joan S Steffan; Stefano L Sensi; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

9.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

10.  Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.

Authors:  Veronica Costa; Marta Giacomello; Roman Hudec; Raffaele Lopreiato; Gennady Ermak; Dmitri Lim; Walter Malorni; Kelvin J A Davies; Ernesto Carafoli; Luca Scorrano
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

View more
  16 in total

1.  Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.

Authors:  Svitlana Yablonska; Vinitha Ganesan; Lisa M Ferrando; JinHo Kim; Anna Pyzel; Oxana V Baranova; Nicolas K Khattar; Timothy M Larkin; Sergei V Baranov; Ning Chen; Colleen E Strohlein; Donté A Stevens; Xiaomin Wang; Yue-Fang Chang; Mark E Schurdak; Diane L Carlisle; Jonathan S Minden; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

2.  Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.

Authors:  Yuqiu Wu; Kimiko Kazumura; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2015-04-12       Impact factor: 3.575

3.  Sustained Hippocampal Synaptic Pathophysiology Following Single and Repeated Closed-Head Concussive Impacts.

Authors:  John McDaid; Clark A Briggs; Nikki M Barrington; Daniel A Peterson; Dorothy A Kozlowski; Grace E Stutzmann
Journal:  Front Cell Neurosci       Date:  2021-03-31       Impact factor: 5.505

Review 4.  Calcium-Handling Defects and Neurodegenerative Disease.

Authors:  Sean Schrank; Nikki Barrington; Grace E Stutzmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

5.  Physiological Function and Characterization of TRPCs in Neurons.

Authors:  Yuyang Sun; Pramod Sukumaran; Bidhan C Bandyopadhyay; Brij B Singh
Journal:  Cells       Date:  2014-05-21       Impact factor: 6.600

Review 6.  Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.

Authors:  Andrew F Leuchter; Aimee M Hunter; David E Krantz; Ian A Cook
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

7.  Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.

Authors:  Evgeny D Nekrasov; Vladimir A Vigont; Sergey A Klyushnikov; Olga S Lebedeva; Ekaterina M Vassina; Alexandra N Bogomazova; Ilya V Chestkov; Tatiana A Semashko; Elena Kiseleva; Lyubov A Suldina; Pavel A Bobrovsky; Olga A Zimina; Maria A Ryazantseva; Anton Yu Skopin; Sergey N Illarioshkin; Elena V Kaznacheyeva; Maria A Lagarkova; Sergey L Kiselev
Journal:  Mol Neurodegener       Date:  2016-04-14       Impact factor: 14.195

8.  Huntington's Disease: Calcium Dyshomeostasis and Pathology Models.

Authors:  Y A Kolobkova; V A Vigont; A V Shalygin; E V Kaznacheyeva
Journal:  Acta Naturae       Date:  2017 Apr-Jun       Impact factor: 1.845

9.  Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease.

Authors:  Magdalena Czeredys; Joanna Gruszczynska-Biegala; Teresa Schacht; Axel Methner; Jacek Kuznicki
Journal:  Front Mol Neurosci       Date:  2013-11-25       Impact factor: 5.639

10.  Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington's Disease.

Authors:  Agnese De Mario; Chiara Scarlatti; Veronica Costiniti; Simona Primerano; Raffaele Lopreiato; Tito Calì; Marisa Brini; Marta Giacomello; Ernesto Carafoli
Journal:  PLoS Curr       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.